 | • レポートコード：MRC309Z7954 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の眼科用非ステロイド性抗炎症薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の眼科用非ステロイド性抗炎症薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 眼科用非ステロイド性抗炎症薬の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 眼科用非ステロイド性抗炎症薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・プラノプロフェン点眼液、ジクロフェナクナトリウム点眼液、ブロムフェナクナトリウム点眼液、その他 用途別セグメント ・病院、診療所、その他 主要な市場プレーヤー ・AbbVie、Bausch Health、Bayer、Dossa Pharmaceuticals、GlaxoSmithKline、Janssen Pharmaceuticals、Novartis、Pfizer、Sun Pharmaceutical Industries、Senju Pharmaceutical、Sichuan Heyi Pharmaceutical、Shandong Haishan Pharmaceutical、Guangdong Zhongsheng Pharmaceutical、Hangzhou Minsheng Pharmaceutical、Cisen Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、眼科用非ステロイド性抗炎症薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な眼科用非ステロイド性抗炎症薬メーカーの企業概要、2019年～2022年までの眼科用非ステロイド性抗炎症薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な眼科用非ステロイド性抗炎症薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別眼科用非ステロイド性抗炎症薬の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの眼科用非ステロイド性抗炎症薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での眼科用非ステロイド性抗炎症薬市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および眼科用非ステロイド性抗炎症薬の産業チェーンを掲載しています。 ・第14、15章では、眼科用非ステロイド性抗炎症薬の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 眼科用非ステロイド性抗炎症薬の概要 - 種類別分析（2018年vs2022年vs2029年）：プラノプロフェン点眼液、ジクロフェナクナトリウム点眼液、ブロムフェナクナトリウム点眼液、その他 - 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他 - 世界の眼科用非ステロイド性抗炎症薬市場規模・予測 - 世界の眼科用非ステロイド性抗炎症薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - AbbVie、Bausch Health、Bayer、Dossa Pharmaceuticals、GlaxoSmithKline、Janssen Pharmaceuticals、Novartis、Pfizer、Sun Pharmaceutical Industries、Senju Pharmaceutical、Sichuan Heyi Pharmaceutical、Shandong Haishan Pharmaceutical、Guangdong Zhongsheng Pharmaceutical、Hangzhou Minsheng Pharmaceutical、Cisen Pharmaceutical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：プラノプロフェン点眼液、ジクロフェナクナトリウム点眼液、ブロムフェナクナトリウム点眼液、その他 ・用途別分析2018年-2029年：病院、診療所、その他 ・眼科用非ステロイド性抗炎症薬の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・眼科用非ステロイド性抗炎症薬のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・眼科用非ステロイド性抗炎症薬のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・眼科用非ステロイド性抗炎症薬の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・眼科用非ステロイド性抗炎症薬の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Non-steroidal Anti-inflammatory Drugs for Ophthalmology market size was valued at USD 956.9 million in 2022 and is forecast to a readjusted size of USD 1814.3 million by 2029 with a CAGR of 9.6% during review period.
Non-steroidal anti-inflammatory drugs have been widely used in ophthalmology clinically due to the lack of adverse reactions such as increased intraocular pressure, secondary infection and cataracts caused by glucocorticoids
The Global Info Research report includes an overview of the development of the Non-steroidal Anti-inflammatory Drugs for Ophthalmology industry chain, the market status of Hospital (Pranoprofen Eye Drops, Diclofenac Sodium Eye Drops), Clinic (Pranoprofen Eye Drops, Diclofenac Sodium Eye Drops), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-steroidal Anti-inflammatory Drugs for Ophthalmology.
Regionally, the report analyzes the Non-steroidal Anti-inflammatory Drugs for Ophthalmology markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-steroidal Anti-inflammatory Drugs for Ophthalmology market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-steroidal Anti-inflammatory Drugs for Ophthalmology market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-steroidal Anti-inflammatory Drugs for Ophthalmology industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Pranoprofen Eye Drops, Diclofenac Sodium Eye Drops).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-steroidal Anti-inflammatory Drugs for Ophthalmology market.
Regional Analysis: The report involves examining the Non-steroidal Anti-inflammatory Drugs for Ophthalmology market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-steroidal Anti-inflammatory Drugs for Ophthalmology market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-steroidal Anti-inflammatory Drugs for Ophthalmology:
Company Analysis: Report covers individual Non-steroidal Anti-inflammatory Drugs for Ophthalmology manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-steroidal Anti-inflammatory Drugs for Ophthalmology This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Non-steroidal Anti-inflammatory Drugs for Ophthalmology. It assesses the current state, advancements, and potential future developments in Non-steroidal Anti-inflammatory Drugs for Ophthalmology areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-steroidal Anti-inflammatory Drugs for Ophthalmology market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-steroidal Anti-inflammatory Drugs for Ophthalmology market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Pranoprofen Eye Drops
Diclofenac Sodium Eye Drops
Bromfenac Sodium Eye Drops
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
AbbVie
Bausch Health
Bayer
Dossa Pharmaceuticals
GlaxoSmithKline
Janssen Pharmaceuticals
Novartis
Pfizer
Sun Pharmaceutical Industries
Senju Pharmaceutical
Sichuan Heyi Pharmaceutical
Shandong Haishan Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Hangzhou Minsheng Pharmaceutical
Cisen Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-steroidal Anti-inflammatory Drugs for Ophthalmology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-steroidal Anti-inflammatory Drugs for Ophthalmology, with price, sales, revenue and global market share of Non-steroidal Anti-inflammatory Drugs for Ophthalmology from 2018 to 2023.
Chapter 3, the Non-steroidal Anti-inflammatory Drugs for Ophthalmology competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-steroidal Anti-inflammatory Drugs for Ophthalmology breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-steroidal Anti-inflammatory Drugs for Ophthalmology market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-steroidal Anti-inflammatory Drugs for Ophthalmology.
Chapter 14 and 15, to describe Non-steroidal Anti-inflammatory Drugs for Ophthalmology sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs for Ophthalmology
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pranoprofen Eye Drops
1.3.3 Diclofenac Sodium Eye Drops
1.3.4 Bromfenac Sodium Eye Drops
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size & Forecast
1.5.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (2018-2029)
1.5.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.1.4 AbbVie Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments/Updates
2.2 Bausch Health
2.2.1 Bausch Health Details
2.2.2 Bausch Health Major Business
2.2.3 Bausch Health Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.2.4 Bausch Health Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bausch Health Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.3.4 Bayer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Recent Developments/Updates
2.4 Dossa Pharmaceuticals
2.4.1 Dossa Pharmaceuticals Details
2.4.2 Dossa Pharmaceuticals Major Business
2.4.3 Dossa Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.4.4 Dossa Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Dossa Pharmaceuticals Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.5.4 GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GlaxoSmithKline Recent Developments/Updates
2.6 Janssen Pharmaceuticals
2.6.1 Janssen Pharmaceuticals Details
2.6.2 Janssen Pharmaceuticals Major Business
2.6.3 Janssen Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.6.4 Janssen Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Janssen Pharmaceuticals Recent Developments/Updates
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.7.4 Novartis Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.8.4 Pfizer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments/Updates
2.9 Sun Pharmaceutical Industries
2.9.1 Sun Pharmaceutical Industries Details
2.9.2 Sun Pharmaceutical Industries Major Business
2.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.9.4 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.10 Senju Pharmaceutical
2.10.1 Senju Pharmaceutical Details
2.10.2 Senju Pharmaceutical Major Business
2.10.3 Senju Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.10.4 Senju Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Senju Pharmaceutical Recent Developments/Updates
2.11 Sichuan Heyi Pharmaceutical
2.11.1 Sichuan Heyi Pharmaceutical Details
2.11.2 Sichuan Heyi Pharmaceutical Major Business
2.11.3 Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.11.4 Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sichuan Heyi Pharmaceutical Recent Developments/Updates
2.12 Shandong Haishan Pharmaceutical
2.12.1 Shandong Haishan Pharmaceutical Details
2.12.2 Shandong Haishan Pharmaceutical Major Business
2.12.3 Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.12.4 Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shandong Haishan Pharmaceutical Recent Developments/Updates
2.13 Guangdong Zhongsheng Pharmaceutical
2.13.1 Guangdong Zhongsheng Pharmaceutical Details
2.13.2 Guangdong Zhongsheng Pharmaceutical Major Business
2.13.3 Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.13.4 Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
2.14 Hangzhou Minsheng Pharmaceutical
2.14.1 Hangzhou Minsheng Pharmaceutical Details
2.14.2 Hangzhou Minsheng Pharmaceutical Major Business
2.14.3 Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.14.4 Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
2.15 Cisen Pharmaceutical
2.15.1 Cisen Pharmaceutical Details
2.15.2 Cisen Pharmaceutical Major Business
2.15.3 Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.15.4 Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Cisen Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Non-steroidal Anti-inflammatory Drugs for Ophthalmology by Manufacturer
3.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Manufacturer (2018-2023)
3.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-steroidal Anti-inflammatory Drugs for Ophthalmology by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Manufacturer Market Share in 2022
3.4.2 Top 6 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Manufacturer Market Share in 2022
3.5 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Overall Company Footprint Analysis
3.5.1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Region Footprint
3.5.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Company Product Type Footprint
3.5.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Region
4.1.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2018-2029)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2018-2029)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Region (2018-2029)
4.2 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
4.3 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
4.4 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
4.5 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
4.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
5.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Type (2018-2029)
5.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
6.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Application (2018-2029)
6.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Application (2018-2029)
7 North America
7.1 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
7.2 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
7.3 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country
7.3.1 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2029)
7.3.2 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
8.2 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
8.3 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country
8.3.1 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Region
9.3.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
10.2 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
10.3 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country
10.3.1 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2029)
10.3.2 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country
11.3.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Drivers
12.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Restraints
12.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Non-steroidal Anti-inflammatory Drugs for Ophthalmology and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-steroidal Anti-inflammatory Drugs for Ophthalmology
13.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Production Process
13.4 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Typical Distributors
14.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer